A year since COVID-19 was declared a worldwide emergency, experts warn that a subsequent mental health pandemic is imminent, due to the lasting adverse impacts of stress, anxiety and isolation. This year’s Annual Meeting offers...
Read MoreFriday, April 30, 2021 11:00 a.m. – 5:30 p.m. ET Pre-Conference Expo Virtual Exhibit Gallery Product Theater Showcases Saturday, May 1, 2021 10:00 a.m. – 11:00 a.m. ET Opening Session (Plenary), Featuring Keynote Speaker Isabel...
Read MoreSchedule Friday, April 30, 2021 Noon – 1:00 p.m. ET Supported by Axsome Therapeutics Inc. [Product Theater 1] New Pathways in Depression: Potential to Improve Clinical Outcomes Roger S. McIntyre MD, FRCP Professor of...
Read MoreAPA is pleased to announce that Anthony Fauci, M.D., director of the National Institute of Allergy and Infectious Diseases will deliver the 2021 William C. Menninger Memorial Convocation Lecture on May 2. At NIAID, Fauci...
Read More
Prof. Tony Traboulsee talks to Physician’s Weekly about his study of tolebrutinib Presented at the...
Read More
Recommendations still oppose pregnancy during MS therapy Women with relapsing multiple sclerosis...
Read More
Reduction in lesion activity seen as early as 8 weeks Patients diagnosed with relapsing...
Read MoreAlthough the CheckMate-9ER trial, comparing cabozantinib plus nivolumab to sunitinib in frontline metastatic renal cell carcinoma (mRCC), had recently demonstrated improved progression-free survival (PFS) and overall survival...
Read More
Patients with hidradenitis suppurativa were asked about their satisfaction regarding telemedicine...
Read More
First author: Niki Nourmohammadi The COVID-19 pandemic has been associated with psychological...
Read More
Presented by: Prof. Mario Lacouture, Memorial Sloan Kettering Cancer Centre As advances in breast...
Read More
A side effect that might not be the first to think about in the COVID-19 pandemic concerns wearing...
Read More
Presented by: Jules Lipoff (University of Pennsylvania), Elizabeth Jones (Thomas Jefferson...
Read More
The importance of sunscreen has been acknowledged globally. Recent topics of discussion include...
Read MoreManagement of patients with multiple sclerosis (MS) in the era of disease modifying therapies (DMT) relies heavily on magnetic resonance imaging (MRI) and the support of dedicated multidisciplinary teams (MDTs). While decisions...
Read More
For patients with multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD)...
Read MoreDue to the COVID-19 pandemic, the 2021 American Academy of Neurology Annual Meeting, the world’s premier neurology meeting, will be held in a fully virtual format from April 17-22. It will include: Over 90 expert-led CME...
Read MoreCognitive impairment is a common and disabling feature of multiple sclerosis (MS), but a precise characterization of cognitive phenotypes in MS patients is still lacking. This study identified five cognitive phenotypes:...
Read MoreThe study team compared disability accrual in primary and secondary progressive multiple sclerosis (PPMS, SPMS) in the international MSBase cohort, using multivariable survival models, and applying objective diagnostic criteria...
Read More
